Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

Treatment and outcome of the patients with rhabdomyosarcoma of the biliary tree: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS).

Urla C, Warmann SW, Sparber-Sauer M, Schuck A, Leuschner I, Klingebiel T, Blumenstock G, Seitz G, Koscielniak E, Fuchs J.

BMC Cancer. 2019 Oct 14;19(1):945. doi: 10.1186/s12885-019-6172-5.

2.

Variations of sex development: The first German interdisciplinary consensus paper.

Krege S, Eckoldt F, Richter-Unruh A, Köhler B, Leuschner I, Mentzel HJ, Moss A, Schweizer K, Stein R, Werner-Rosen K, Wieacker P, Wiesemann C, Wünsch L, Richter-Appelt H.

J Pediatr Urol. 2019 Apr;15(2):114-123. doi: 10.1016/j.jpurol.2018.10.008. Epub 2018 Nov 17. Review.

PMID:
30713084
3.

Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol.

Gooskens SL, Graf N, Furtwängler R, Spreafico F, Bergeron C, Ramírez-Villar GL, Godzinski J, Rübe C, Janssens GO, Vujanic GM, Leuschner I, Coulomb-L'Hermine A, Smets AM, de Camargo B, Stoneham S, van Tinteren H, Pritchard-Jones K, van den Heuvel-Eibrink MM; International Society of Paediatric Oncology–Renal Tumour Study Group (SIOP–RTSG).

Nat Rev Urol. 2018 May;15(5):309-319. doi: 10.1038/nrurol.2018.14. Epub 2018 Feb 27. Review.

PMID:
29485128
4.

Treatment and outcome of patients with localized intrathoracic and chest wall rhabdomyosarcoma: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS).

Fuchs J, Urla C, Sparber-Sauer M, Schuck A, Leuschner I, Klingebiel T, Blumenstock G, Seitz G, Koscielniak E.

J Cancer Res Clin Oncol. 2018 May;144(5):925-934. doi: 10.1007/s00432-018-2603-y. Epub 2018 Feb 20.

PMID:
29464349
5.

Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS).

Sparber-Sauer M, Seitz G, von Kalle T, Vokuhl C, Leuschner I, Scheer M, Münter M, Ljungman G, Bielack SS, Niggli F, Ladenstein R, Klingebiel T, Fuchs J, Koscielniak E; CWS Study Group.

Pediatr Blood Cancer. 2018 May;65(5):e26943. doi: 10.1002/pbc.26943. Epub 2018 Jan 5.

PMID:
29316163
6.

ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study.

Vokuhl C, Nourkami-Tutdibi N, Furtwängler R, Gessler M, Graf N, Leuschner I.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26925. Epub 2017 Dec 29.

PMID:
29286563
7.

Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms.

Zapka P, Dörner E, Dreschmann V, Sakamato N, Kristiansen G, Calaminus G, Vokuhl C, Leuschner I, Pietsch T.

J Neuropathol Exp Neurol. 2018 Feb 1;77(2):119-127. doi: 10.1093/jnen/nlx106.

PMID:
29237087
8.

Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.

van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, van Tinteren H, Furtwängler R, Verschuur AC, Vujanic GM, Leuschner I, Brok J, Rübe C, Smets AM, Janssens GO, Godzinski J, Ramírez-Villar GL, de Camargo B, Segers H, Collini P, Gessler M, Bergeron C, Spreafico F, Graf N; International Society of Paediatric Oncology — Renal Tumour Study Group (SIOP–RTSG).

Nat Rev Urol. 2017 Dec;14(12):743-752. doi: 10.1038/nrurol.2017.163. Epub 2017 Oct 31. Review.

PMID:
29089605
9.

TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia.

Wegert J, Vokuhl C, Ziegler B, Ernestus K, Leuschner I, Furtwängler R, Graf N, Gessler M.

J Pathol Clin Res. 2017 Aug 14;3(4):234-248. doi: 10.1002/cjp2.77. eCollection 2017 Oct.

10.

Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach.

Storck S, Kennedy AL, Marcus KJ, Teot L, Vaughn J, Gnekow AK, Märkl B, Leuschner I, DuBois SG, French CA, Frühwald MC.

Pediatr Hematol Oncol. 2017 May;34(4):231-237. doi: 10.1080/08880018.2017.1363839. Epub 2017 Oct 17.

PMID:
29040054
11.

[Infantile hemangiopericytoma of the nasal cavity].

Heyduck A, Wemmert S, Leuschner I, Schick B.

HNO. 2018 May;66(5):396-398. doi: 10.1007/s00106-017-0421-1. German.

PMID:
28940007
12.

High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience.

Furtwängler R, Kager L, Melchior P, Rübe C, Ebinger M, Nourkami-Tutdibi N, Niggli F, Warmann S, Hubertus J, Amman G, Leuschner I, Vokuhl C, Graf N, Frühwald MC.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26746. Epub 2017 Aug 26.

PMID:
28843054
13.

2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors.

Simon T, Hero B, Schulte JH, Deubzer H, Hundsdoerfer P, von Schweinitz D, Fuchs J, Schmidt M, Prasad V, Krug B, Timmermann B, Leuschner I, Fischer M, Langer T, Astrahantseff K, Berthold F, Lode H, Eggert A.

Klin Padiatr. 2017 May;229(3):147-167. doi: 10.1055/s-0043-103086. Epub 2017 May 30.

PMID:
28561228
14.

Strong Expression and Amplification of IGF1R in Pleuropulmonary Blastomas.

Vokuhl C, de Leon-Escapini L, Leuschner I.

Pediatr Dev Pathol. 2017 Nov-Dec;20(6):475-481. doi: 10.1177/1093526617700945. Epub 2017 Apr 6.

PMID:
28382840
15.

Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.

Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, Deubzer H, Dirksen U, Eckert C, Eggert A, Erlacher M, Fleischhack G, Frühwald MC, Gnekow A, Goehring G, Graf N, Hanenberg H, Hauer J, Hero B, Hettmer S, von Hoff K, Horstmann M, Hoyer J, Illig T, Kaatsch P, Kappler R, Kerl K, Klingebiel T, Kontny U, Kordes U, Körholz D, Koscielniak E, Kramm CM, Kuhlen M, Kulozik AE, Lamottke B, Leuschner I, Lohmann DR, Meinhardt A, Metzler M, Meyer LH, Moser O, Nathrath M, Niemeyer CM, Nustede R, Pajtler KW, Paret C, Rasche M, Reinhardt D, Rieß O, Russo A, Rutkowski S, Schlegelberger B, Schneider D, Schneppenheim R, Schrappe M, Schroeder C, von Schweinitz D, Simon T, Sparber-Sauer M, Spix C, Stanulla M, Steinemann D, Strahm B, Temming P, Thomay K, von Bueren AO, Vorwerk P, Witt O, Wlodarski M, Wössmann W, Zenker M, Zimmermann S, Pfister SM, Kratz CP.

Am J Med Genet A. 2017 Apr;173(4):1017-1037. doi: 10.1002/ajmg.a.38142. Epub 2017 Feb 7. Review.

PMID:
28168833
16.

The impact of local control in the treatment of type II/III pleuropulmonary blastoma. Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS).

Sparber-Sauer M, Seitz G, Kirsch S, Vokuhl C, Leuschner I, Dantonello TM, Scheer M, von Kalle T, Ljungman G, Bielack SS, Klingebiel T, Fuchs J, Koscielniak E; CWS Study Group.

J Surg Oncol. 2017 Feb;115(2):164-172. doi: 10.1002/jso.24416. Epub 2017 Jan 19.

PMID:
28103635
17.

LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma.

Dräger J, Simon-Keller K, Pukrop T, Klemm F, Wilting J, Sticht C, Dittmann K, Schulz M, Leuschner I, Marx A, Hahn H.

Oncotarget. 2017 Jan 10;8(2):3259-3273. doi: 10.18632/oncotarget.13887.

18.

Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.

Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P.

Lancet Oncol. 2017 Jan;18(1):122-131. doi: 10.1016/S1470-2045(16)30598-8. Epub 2016 Nov 22.

19.

Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and -2002P.

Seitz G, Fuchs J, Martus P, Klingebiel T, Leuschner I, Schuck A, Dantonello TM, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe (CWS).

Ann Surg. 2016 Dec;264(6):1148-1155.

PMID:
27828824
20.

IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice.

Bergmann J, Müller M, Baumann N, Reichert M, Heneweer C, Bolik J, Lücke K, Gruber S, Carambia A, Boretius S, Leuschner I, Becker T, Rabe B, Herkel J, Wunderlich FT, Mittrücker HW, Rose-John S, Schmidt-Arras D.

Hepatology. 2017 Jan;65(1):89-103. doi: 10.1002/hep.28874. Epub 2016 Nov 22.

PMID:
27770462
21.

Synovial Sarcoma Recurrence in Children and Young Adults.

Scheer M, Dantonello T, Hallmen E, Blank B, Sparber-Sauer M, Vokuhl C, Leuschner I, Münter MW, von Kalle T, Bielack SS, Klingebiel T, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe [CWS].

Ann Surg Oncol. 2016 Dec;23(Suppl 5):618-626. Epub 2016 Sep 8.

PMID:
27638676
22.

The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.

Stegmaier S, Leuschner I, Poremba C, Ladenstein R, Kazanowska B, Ljungman G, Scheer M, Blank B, Bielack S, Klingebiel T, Koscielniak E.

Pediatr Blood Cancer. 2017 Jan;64(1):89-95. doi: 10.1002/pbc.26206. Epub 2016 Sep 13.

PMID:
27621063
23.

Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed.

Decarolis B, Simon T, Krug B, Leuschner I, Vokuhl C, Kaatsch P, von Schweinitz D, Klingebiel T, Mueller I, Schweigerer L, Berthold F, Hero B.

BMC Cancer. 2016 Jul 27;16:542. doi: 10.1186/s12885-016-2513-9.

24.

CNS germinomas are characterized by global demethylation, chromosomal instability and mutational activation of the Kit-, Ras/Raf/Erk- and Akt-pathways.

Schulte SL, Waha A, Steiger B, Denkhaus D, Dörner E, Calaminus G, Leuschner I, Pietsch T.

Oncotarget. 2016 Aug 23;7(34):55026-55042. doi: 10.18632/oncotarget.10392.

25.

Improvements in the Treatment of Patients Suffering from Bladder-Prostate Rhabdomyosarcoma: A Report from the CWS-2002P Trial.

Seitz G, Fuchs J, Sparber-Sauer M, Leuschner I, Godzinski J, Klingebiel T, Schuck A, Martus P, Dantonello TM, Koscielniak E.

Ann Surg Oncol. 2016 Nov;23(12):4067-4072. Epub 2016 Jul 7.

PMID:
27387676
26.

Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?

Vokuhl C, Oyen F, Häberle B, von Schweinitz D, Schneppenheim R, Leuschner I.

Genes Chromosomes Cancer. 2016 Dec;55(12):925-931. doi: 10.1002/gcc.22390. Epub 2016 Jul 29.

PMID:
27356182
27.

Cellular Profiles and Molecular Mediators of Lesion Cascades in the Placode in Human Open Spinal Neural Tube Defects.

Kowitzke B, Cohrs G, Leuschner I, Koch A, Synowitz M, Mehdorn HM, Held-Feindt J, Knerlich-Lukoschus F.

J Neuropathol Exp Neurol. 2016 Sep;75(9):827-42. doi: 10.1093/jnen/nlw057. Epub 2016 Jun 28.

PMID:
27354486
28.

Diagnosis and Treatment of Nasopharyngeal Carcinoma in Children and Adolescents - Recommendations of the GPOH-NPC Study Group.

Kontny U, Franzen S, Behrends U, Bührlen M, Christiansen H, Delecluse H, Eble M, Feuchtinger T, Gademann G, Granzen B, Kratz CP, Lassay L, Leuschner I, Mottaghy FM, Schmitt C, Staatz G, Timmermann B, Vorwerk P, Wilop S, Wolff HA, Mertens R.

Klin Padiatr. 2016 Apr;228(3):105-12. doi: 10.1055/s-0041-111180. Epub 2016 May 2. Review.

PMID:
27135270
29.

Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group.

Scheer M, Dantonello T, Hallmen E, Vokuhl C, Leuschner I, Sparber-Sauer M, Kazanowska B, Niggli F, Ladenstein R, Bielack SS, Klingebiel T, Koscielniak E.

Pediatr Blood Cancer. 2016 Jul;63(7):1198-206. doi: 10.1002/pbc.25973. Epub 2016 Mar 22.

PMID:
27003095
30.

Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story.

Kenny C, Bausenwein S, Lazaro A, Furtwängler R, Gooskens SL, van den Heuvel Eibrink M, Vokuhl C, Leuschner I, Graf N, Gessler M, O'Sullivan MJ.

J Pathol. 2016 Apr;238(5):617-20. doi: 10.1002/path.4693.

PMID:
27000436
31.

A disintegrin and metalloprotease 10 (ADAM10) is a central regulator of murine liver tissue homeostasis.

Müller M, Wetzel S, Köhn-Gaone J, Chalupsky K, Lüllmann-Rauch R, Barikbin R, Bergmann J, Wöhner B, Zbodakova O, Leuschner I, Martin G, Tiegs G, Rose-John S, Sedlacek R, Tirnitz-Parker JE, Saftig P, Schmidt-Arras D.

Oncotarget. 2016 Apr 5;7(14):17431-41. doi: 10.18632/oncotarget.7836.

32.

The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.

Czauderna P, Haeberle B, Hiyama E, Rangaswami A, Krailo M, Maibach R, Rinaldi E, Feng Y, Aronson D, Malogolowkin M, Yoshimura K, Leuschner I, Lopez-Terrada D, Hishiki T, Perilongo G, von Schweinitz D, Schmid I, Watanabe K, Derosa M, Meyers R.

Eur J Cancer. 2016 Jan;52:92-101. doi: 10.1016/j.ejca.2015.09.023. Epub 2015 Dec 1.

33.

Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity.

Bierkarre H, Harder J, Cuthbert R, Emery P, Leuschner I, Mrowietz U, Hedderich J, McGonagle D, Gläser R.

Scand J Rheumatol. 2016;45(3):188-96. doi: 10.3109/03009742.2015.1091497. Epub 2015 Nov 24.

PMID:
26599663
34.

Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes.

Weber ML, Schneider DT, Offenmüller S, Kaatsch P, Einsiedel HG, Benesch M, Claviez A, Ebinger M, Kramm C, Kratz C, Lawlor J, Leuschner I, Merkel S, Metzler M, Nustede R, Petsch S, Seeger KH, Schlegel PG, Suttorp M, Zolk O, Brecht IB.

Pediatr Blood Cancer. 2016 Apr;63(4):611-7. doi: 10.1002/pbc.25839. Epub 2015 Nov 17.

PMID:
26575411
35.

[Primary liver tumours in childhood].

Schreiber-Dietrich DG, Leuschner I, Tannapfel A, Franke D, Stenzel M, Juengert J, Dietrich CF.

Z Gastroenterol. 2015 Nov;53(11):1267-75. doi: 10.1055/s-0041-105700. Epub 2015 Nov 12. Review. German.

PMID:
26562401
36.

The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney.

Gooskens SL, Kenny C, Lazaro A, O'Meara E, van Tinteren H, Spreafico F, Vujanic G, Leuschner I, Coulomb-L'Herminé A, Perotti D, de Camargo B, Bergeron C, Acha García T, Tanaka M, Pieters R, Pritchard-Jones K, Graf N, van den Heuvel-Eibrink MM, O'Sullivan MJ.

Genes Chromosomes Cancer. 2016 Feb;55(2):143-7. doi: 10.1002/gcc.22320. Epub 2015 Nov 6.

PMID:
26542179
37.

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.

Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, Menon R, Krämer A, Roncaioli JL, Sand F, Heuckmann JM, Ikram F, Schmidt R, Ackermann S, Engesser A, Kahlert Y, Vogel W, Altmüller J, Nürnberg P, Thierry-Mieg J, Thierry-Mieg D, Mariappan A, Heynck S, Mariotti E, Henrich KO, Gloeckner C, Bosco G, Leuschner I, Schweiger MR, Savelyeva L, Watkins SC, Shao C, Bell E, Höfer T, Achter V, Lang U, Theissen J, Volland R, Saadati M, Eggert A, de Wilde B, Berthold F, Peng Z, Zhao C, Shi L, Ortmann M, Büttner R, Perner S, Hero B, Schramm A, Schulte JH, Herrmann C, O'Sullivan RJ, Westermann F, Thomas RK, Fischer M.

Nature. 2015 Oct 29;526(7575):700-4. doi: 10.1038/nature14980. Epub 2015 Oct 14.

38.

[Histiocytic diseases in childhood and adolescence].

Vokuhl C, Oschlies I, Klapper W, Leuschner I.

Pathologe. 2015 Sep;36(5):443-50. doi: 10.1007/s00292-015-0043-x. Review. German.

PMID:
26292932
39.

How to Name Papillary Tumors of the Bladder in Children: Transitional Cell Carcinoma or Papillary Urothelial Neoplasm of Low Malignant Potential?

Umlauf VN, Coerdt W, Leuschner I, Schröder A, Stein R, Beetz R.

Urology. 2015 Aug;86(2):379-83. doi: 10.1016/j.urology.2015.04.021. Epub 2015 Jul 10.

PMID:
26169007
40.

Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.

Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, Oldenburger F, Boccon-Gibod L, Leuschner I, Vujanic G, Sandstedt B, de Kraker J, van Tinteren H, Graf N; SIOP Renal Tumours Study Group.

Lancet. 2015 Sep 19;386(9999):1156-64. doi: 10.1016/S0140-6736(14)62395-3. Epub 2015 Jul 9.

41.

Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe.

Bölling T, Braun-Munzinger G, Burdach S, Calaminus G, Craft A, Delattre O, Deley MC, Dirksen U, Dockhorn-Dworniczak B, Dunst J, Engel S, Faldum A, Fröhlich B, Gadner H, Göbel U, Gosheger G, Hardes J, Hawkins DS, Hjorth L, Hoffmann C, Kovar H, Kruseova J, Ladenstein R, Leuschner I, Lewis IJ, Oberlin O, Paulussen M, Potratz J, Ranft A, Rössig C, Rübe C, Sauer R, Schober O, Schuck A, Timmermann B, Tirode F, van den Berg H, van Valen F, Vieth V, Willich N, Winkelmann W, Whelan J, Womer RB.

Klin Padiatr. 2015 May;227(3):108-15. doi: 10.1055/s-0035-1545263. Epub 2015 May 18.

PMID:
25985445
42.

Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia.

Alten J, Klapper W, Leuschner I, Eckert C, Beier R, Vallo E, Krause M, Claviez A, Vieth S, Bleckmann K, Möricke A, Schrappe M, Cario G.

Pediatr Blood Cancer. 2015 Sep;62(9):1656-60. doi: 10.1002/pbc.25523. Epub 2015 Apr 1. Review.

PMID:
25833113
43.

Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.

Wegert J, Ishaque N, Vardapour R, Geörg C, Gu Z, Bieg M, Ziegler B, Bausenwein S, Nourkami N, Ludwig N, Keller A, Grimm C, Kneitz S, Williams RD, Chagtai T, Pritchard-Jones K, van Sluis P, Volckmann R, Koster J, Versteeg R, Acha T, O'Sullivan MJ, Bode PK, Niggli F, Tytgat GA, van Tinteren H, van den Heuvel-Eibrink MM, Meese E, Vokuhl C, Leuschner I, Graf N, Eils R, Pfister SM, Kool M, Gessler M.

Cancer Cell. 2015 Feb 9;27(2):298-311. doi: 10.1016/j.ccell.2015.01.002.

44.

Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor.

Kerl K, Oyen F, Leuschner I, Schneppenheim R, Nagel I, Siebert R, Groll AH, Hartmann W, Barth PJ, Bartelheim K, Seringer A, Wardelmann E, Frühwald MC.

Pediatr Blood Cancer. 2015 May;62(5):897-900. doi: 10.1002/pbc.25412. Epub 2015 Feb 7.

PMID:
25663425
45.

Ewing sarcoma of the posterior fossa in an adolescent girl.

Stark AM, Leuschner I, Mehdorn HM, Claviez A.

Case Rep Med. 2014;2014:439830. doi: 10.1155/2014/439830. Epub 2014 Dec 29.

46.

Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).

van den Heuvel-Eibrink MM, van Tinteren H, Bergeron C, Coulomb-L'Hermine A, de Camargo B, Leuschner I, Sandstedt B, Acha T, Godzinski J, Oldenburger F, Gooskens SL, de Kraker J, Vujanic GM, Pritchard-Jones K, Graf N.

Eur J Cancer. 2015 Mar;51(4):498-506. doi: 10.1016/j.ejca.2014.12.011. Epub 2015 Jan 12.

PMID:
25592561
47.

Reply to: "TERT promoter mutation during development of hepatoblastoma to hepatocellular carcinoma".

Kappler R, Leuschner I, von Schweinitz D.

J Hepatol. 2015 Feb;62(2):498-9. doi: 10.1016/j.jhep.2014.10.043. Epub 2014 Nov 5. No abstract available.

48.

Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.

Göbel U, Calaminus G, Haas R, Teske C, Schönberger S, Schneider DT, Leuschner I, Harms D.

Klin Padiatr. 2014 Nov;226(6-7):316-22. doi: 10.1055/s-0034-1387748. Epub 2014 Nov 28.

PMID:
25431864
49.

Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor.

Seeringer A, Reinhard H, Hasselblatt M, Schneppenheim R, Siebert R, Bartelheim K, Leuschner I, Frühwald MC.

Cancer Genet. 2014 Sep;207(9):429-33. doi: 10.1016/j.cancergen.2014.06.028. Epub 2014 Jul 3.

PMID:
25262118
50.

Malignant rhabdoid tumor of the kidney: significantly improved response to pre-operative treatment intensified with doxorubicin.

Furtwängler R, Nourkami-Tutdibi N, Leuschner I, Vokuhl C, Niggli F, Kager L, Ebinger M, Frühwald MC, Graf N; GPOH Nephroblastoma Study Committee.

Cancer Genet. 2014 Sep;207(9):434-6. doi: 10.1016/j.cancergen.2014.07.001. Epub 2014 Jul 18.

PMID:
25242089

Supplemental Content

Loading ...
Support Center